Contact
Please use this form to send email to PR contact of this press release:
Aptevo Therapeutics’ Novel Bispecific Antibody Therapeutic APVO436 Shows Broad Activity in Primary Human AML Samples
TO:
Please use this form to send email to PR contact of this press release:
Aptevo Therapeutics’ Novel Bispecific Antibody Therapeutic APVO436 Shows Broad Activity in Primary Human AML Samples
TO: